Biopharma 2022: 5 Trends Shaping the Industry

Just 10 months ago, pharma and biotech companies rode a wave of pandemic-driven innovation and historic funding levels into what many hoped would be another banner year.

Over Five Years, Clinical Studies In The UK Have Plunged

The constraints that COVID-19 imposed on collaboration in other areas of medicine have had a limiting effect on ecology of clinical trial research in Britain.

FDA To Fund $38 Million To Fuel 4-Year Rare Disease Research

Research into uncommon ailments that also include amyotrophic lateral sclerosis- ALS will get $38 million in funding from the FDA during the next four years.

ICR scientists study cancer response to new class of drugs

Stomach tumours can reject a novel class of medicines, suggesting drug resistance can be forecast by ICR, London and The Royal Marsden NHS Foundation Trust.

Bora Pharmaceutical makes strategic appointment to strengthen global manufacturing capabilities

Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO), has appointed Don Liscombe as their Vice President and General Manager to lead its flagship.

Recipharm strengthens pre-filled syringe and cartridge offering with new investment

Global contract development and manufacturing organisation (CDMO) Recipharm, has invested in a new high speed filling line for pre-filled syringes and cartridges at its facility in Wasserburg.

Terumo Pharmaceutical Solutions offers next generation answer for challenging biotech drugs

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of primary container, injection and infusion therapy devices.